INKT Latest Press Releases

-- October 2, 2026 --

MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026 Globe Newswire 9:00 AM

-- September 30, 2026 --

MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy Globe Newswire 7:57 AM

-- August 13, 2026 --

MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury Globe Newswire 7:30 AM

-- August 6, 2026 --

MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium Globe Newswire 12:00 PM

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates Globe Newswire 8:19 AM

Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer Business Wire 7:30 AM

-- June 3, 2026 --

MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes